ArticleCancer research2016

A Chimeric Switch-Receptor Targeting PD1 Augments the Efficacy of Second-Generation CAR T Cells in Advanced Solid Tumors.

Xiaojun Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.